Krsnaa Diagnostics shares surged after the company signed a 15-year concession agreement with Punjab Health Systems Corporation. The pact marks its entry into PET-CT diagnostics, with the company set to develop and operate facilities at four government hospitals in Punjab under a PPP model.
The Economic Times
Original source
krsnaa diagnostics
Check live status on DownRightNow
Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lily, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found. CBS News investigative reporter and producer Daniel Gilbert has the story.
Palo Alto Networks Chairman and CEO Nikesh Arora joins 'Mad Money' host Jim Cramer to talk mounting concerns around AI safety, how he thinks AI should be approached from a cybersecurity standpoint, the state of AI spend, and more.
Allahabad HC issues notices to Centre, UP and Noida DM on journalist Satyam Verma’s NSA detention over April 2026 Noida protest; next hearing Oct 7.
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer